Why some stakeholders are not happy about the FDA’s removal of tirzepatide from the drug shortage list.

The highlights of the trade show and its conference agenda - day 3

The highlights of the trade show and its conference agenda - day 2

The highlights of the trade show and its conference agenda - day 1

Flu changes, ever so slightly, year by year and region by region. The vaccine manufacturing industry must bring changes of its own.

The Alliance for RTU has been founded to accelerate and improve manufacturing quality, consistency, and regulatory efficiency.

The Nobel Prize for Medicine has again been awarded jointly, this time for miRNA discovery and its role in gene regulation

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.

AstraZeneca’s FluMist is the first flu vaccine to be approved for self-administration.

Researchers use AI to reprogram glioblastoma cancer cells